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Whole-exome sequencing and an iPSC-
derived cardiomyocyte model provides a 
powerful platform for gene discovery in left 
ventricular hypertrophy
by Zhi, D., Irvin, M. R., Gu, C. C., Stoddard, 
A. J., Lorier, R., Matter, A., Rao, D. C., 
Srinivasasainagendra, V., Tiwari, H. K., Turner, 
A., Broeckel, U., and Arnett, D. K. (2012). Front. 
Gene. 3:92. doi: 10.3389/fgene.2012.00092
In a study published this month in Frontiers 
in Applied Genetic Epidemiology (Zhi et al., 
2012), the authors have studied left ventricu-
lar hypertrophy (LVH), the thickening of the 
myocardium of the left ventricle of the heart, 
which is a trait that can be used as heritable 
predictor of cardiovascular disease, to iden-
tify genomic variants and genes that could 
be used as predictive markers of increased 
left ventricular mass. They used next gen-
eration sequencing to produce data from 
the whole exome of a hypertensive popu-
lation and from total mRNA of a cellular 
model of LVH. The authors identified 31,426 
genomic missense or nonsense mutations in 
seven African American sibling trios with 
high familial left ventricular mass indexed 
to height (LVMH). Using regression analy-
ses, they found out that 295 of these vari-
ants, located in 265 genes, were associated 
significantly to LVMH after adjusting for 
multiple testing. They also produced total 
mRNA sequence data from a cellular model 
of LVH, hypertrophic cardiomyocytes, that 
was compared to the expression data from 
control cardiomyocytes producing a list of 
differentially expressed genes (using as cut 
off a value of P < 0.05 without adjusting 
for multiple testing). The LVH differential 
expression genes were compared with the 
list of genes with LVMH associated variants, 
producing 44 genes that were common to 
both lists. Gene Ontology analysis of the 
authors 44 genes list indicates a significant 
enrichment of genes involved in the cell cycle 
process (Chi test; P = 0.00016, adjusted for 
multiple testing) and overrepresentation in 
the cell adhesion process. Pathway analysis 
indicates that 2 of the 44 common genes 
(THBS1 and COL6A3) are part of the sign-
aling by Platelet-derived Growth Factor 
(PDGF) pathway which has been implicated 
in tissue remodeling, being PDGF a potent 
stimulator of growth. Data from the Gene 
Reference into Function database (GeneRIF) 
in NCBI, indicates that five of these common 
genes (HLA-B, HTT, THBS1, PAPPA, and 
SYNE1) have been implicated in the litera-
ture with cardiovascular risk, heart disease, 
or heart failure in human and in mice, and 
polymorphisms of another (PER3) have 
been associated to the sympathovagal bal-
ance in cardiac control.
When the authors adjusted the P-values 
of the differential expression data for the 
number of tested genes, they reduced the 
initial list to 11 genes with differential 
expression and variants associated to LVMH 
reaching statistical significance. Pathway 
analysis indicates that seven of these genes 
are annotated and belong to pathways such 
as cell cycle, signaling by PDGF, or regula-
tion of Insulin-like Growth Factor among 
others. GeneRIF analysis of this new gene 
list, produced with more stringent crite-
ria for the expression data that reduced to 
25% the number of genes to analyze, shows 
that among the resulting 11 genes still were 
included 3 out of the 6 genes implicated 
with heart conditions or heart control 
(THBS1, PAPPA, and PER3) and one from 
the signaling by PDGF pathway (THBS1). 
This further enrichment in genes involved 
with heart conditions or control is in agree-
ment with the hypothesis of the authors 
that the differential expression data used 
is a good criterion to identify heart disease 
risk genes and, consequently, that the novel 
cellular model of LVH used to obtain the 
expression data could be useful to provide 
functional information of the phenotype.
The authors used another approach to 
select the genes by applying a candidate 
gene prioritization strategy to the 44 initial 
genes using seven different criteria which 
included statistical, linkage, functional, 
conservation, and allele frequency data 
among others. This resulted in five genes 
that satisfied at least three of the seven cri-
teria (HLA-B, HTT, MTSS1, SLC5A12, and 
THBS1). Interestingly, three of them (HLA-
B, HTT, and THBS1) are among the genes 
implicated with heart conditions, being one 
of them among the 11 with significantly dif-
ferential expression after adjusting for the 
number of tests performed. This enrich-
ment of heart condition genes supports that 
the seven criteria used by the authors are 
good predictors to identify LVH risk genes.
None of the two main technologies used 
in this approach, RNA sequencing and whole 
exon-sequencing, is novel in the search for 
gene candidates to cause disease. However, 
the combination of whole exome sequenc-
ing, gene expression data from a cell model 
of the trait, and mainly, the gene prioritiza-
tion strategy using seven additional criteria 
that includes public annotations and statis-
tical data, provides a novel strategy.
In conclusion, the methodology used, 
despite all the limitations described by the 
authors in the article, seem to provide an 
enrichment of genes involved with the trait 
of study, provide new candidates for further 
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studies, and a strategy that could be applied 
to other phenotypes with the pertinent 
modifications.
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